Author(s)

Ihou Majesté Wateba¹, Abago Balaka², Alain Lidaw Bawe¹, Awereou Kotosso¹

¹Tropical and Infectious Diseases Service of CHU SO, Lome, Togo.
²Internal Medicine Service of CHU SO, Lome, Togo.

Objective: To describe the clinical, epidemiological and evolutionary aspects of cryptococcal meningitis. Methods: This was a retrospective descriptive study on all HIV-infected patients who had been hospitalized for cryptococcal meningitis between 2006 and 2016 in the principal structures for the care of HIV infected person in Lomé. The diagnosis of meningitis was clinical and confirmed by the presence of cryptococci on Chinese ink or the detection of CSFsoluble antigens. All patients have made the CD4 rate assay and received an antifungal treatment based on fluconazole or Amphotericin B, followed later by antiretroviral triple therapy. Results: A total of 102 patients infected with cryptococcal meningitis (62 men for 40 women) were found. The sex ratio was 1.55. The median age was 34 years with extremes of 15 to 49 years. Clinically, headache was the symptomatic symptom in 100% of cases, prone to long runs and weight loss respectively in the proportions of 45% and 65%. The mean CD4 cell count was 65 ± 22 cells per mm3. The duration of hospital stay was short (less than 7 days) for the deceased. A total of 62 patients were able to receive treatment, 40 of them with fluconazole and 22 with Amphotericin B. The mortality was very high (65%), 25% were lost to follow-up, and 9.5% still in live 3 months after admission to the hospital. Conclusion: Cryptococcal meningitis has a very reserved prognosis. It is to be feared in cases of severe immunosuppression, hence the early detection of HIV for optimal management is important.

Cryptococcal Meningitis, HIV, Lomé

Wateba, I.M.,Balaka, A., Bawe, A.L. and Kotosso, A. (2017)Cryptococcal Meningitis of the HIV-Infected Person in Lomé: About 102 Cases over 10 Years. World Journal of AIDS, 7, 217-222. https://doi.org/10.4236/wja.2017.73017